Shankar Siva, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses some of the key areas of unmet need regarding the use of radiotherapy for patients with kidney cancer. Some of these areas include optimizing treatment sequencing for patients with oligometastatic disease and the use of radiotherapy for patients with advanced/inoperable localised disease, as well as in the cytoreductive space. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.